Home
Editas Medicine and Vertex Pharmaceuticals: Non-Exclusive License Agreement in Cas9 Gene Editing Technology  

Editas Medicine and Vertex Pharmaceuticals: Non-Exclusive License Agreement in Cas9 Gene Editing Technology  

Today’s Highlights December 13, 2023

Editas Medicine and Vertex Pharmaceuticals in the NEWA
Today December 13, 2023, Editas Medicine (EDIT) announced that it entered into an agreement with Vertex Pharmaceuticals (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
,
December 13, 2023

Other Articles